Developer docs
API playgroundTry for free, no card

Search company profiles

Mutual Capital Partners

Full company profile

uuid0000xcv

Namestring
Mutual Capital Partners
Legal namestring
Mutual Capital Partners
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Mutual Capital Partners (MCP) is a Cleveland, Ohio-based venture capital firm founded in 2004 by Bill Trainor and Wayne Wallace, focused exclusively on healthcare IT and medical device companies. The firm manages four successive funds (MCPF I through MCPF IV), with Fund IV currently active and having made its first investment in early 2023. MCP invests in early to growth-stage companies located primarily in Ohio and the broader Midwest, deliberately avoiding major tech centers to source differentiated deal flow.

The firm's investment criteria target companies with at least $1 million in run-rate revenue, gross margins of 50% or higher, a strong management team, and at least five reference customers who are renewing or expanding. Typical check sizes range from approximately $11M to $15M, deployed across Series A through Series D rounds and select debt financings. Notable portfolio holdings span Cooler Heads (scalp cooling), iotaMotion (cochlear implant insertion systems), Authenticx (voice analytics), Catalyst OrthoScience (orthopedic implants), Checkpoint Surgical, Elevation Spine, Olio Health (post-acute workflow), Redi.Health, and SPR Therapeutics (pain management), with exits including Cardinal Commerce (Visa, 2016), Cleveland HeartLab (Quest Diagnostics, 2017), TGX Medical Systems (Integra LifeSciences, 2017), OrthoHelix Surgical Designs (Tornier, 2012), and RevLocal (Hibu, 2024). Fund I achieved top-quartile returns.

MCP operates as a limited partnership generating revenue through traditional venture capital fund management economics—management fees on committed and deployed capital plus carried interest on successful exits. The four-person team (two co-founder Managing Directors, one Principal, one Senior Associate) sources deals through direct outreach, network introductions, and partnerships with regional angel funds and economic development entities. The firm does not develop proprietary technology products; its competitive position rests on regional deal flow access, co-investment syndicates with RC Capital, River Cities Capital, Blue Heron Capital, Fulcrum Equity Partners, and Revelation Partners, and a strong historical exit track record within healthcare technology investing.

Short descriptiontext

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm founded in 2004 that invests in healthcare IT and medical device companies across Ohio and the broader Midwest, managing four successive funds (MCPF I-IV) with a focus on early to growth-stage companies demonstrating strong unit economics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWestlake, United States
HQ citystring
Westlake
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, medical device investing, healthcare IT funding, early-stage growth capital, Midwest venture capital
Industry1 code
PRIMARYFSANAAAJ
Venture Capital Fund-of-Funds / Multi-Manager Platforms
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeManaged Services
Description

MCP generates revenue through traditional venture capital fund management, including management fees on deployed capital and carried interest (performance fees) on successful portfolio company exits.

mutualcapitalpartners.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that manages multiple funds (MCPF I through MCPF IV) investing equity capital into early- and growth-stage healthcare IT and medical device companies, primarily in Ohio and the broader Midwest. The firm provides portfolio companies with capital, fundraising guidance, networking support, and hands-on operational partnership in addition to financial investment. Investment criteria require companies to have $1M+ in run-rate revenue, 50%+ gross margins, a strong management nucleus, at least five reference customers, and a location outside of major tech centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Top quartile returns on Fund I
Product overview1 text field

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that invests in healthcare IT and medical device companies. The firm operates multiple investment funds (MCPF I through MCPF IV) and provides capital, networking, and advisory support to portfolio companies. The firm's investment focus is on healthcare technology companies with strong management teams, at least $1 million in run-rate revenue, and 50%+ gross margins, located primarily in Ohio and the Midwest. As a VC firm, MCP does not offer a technology product; its services are investment capital deployment and portfolio company support.

Product and service3 records
1Mutual Capital Partners Fund I (MCPF I)
CategoryVenture Capital Fund
Description

MCP's inaugural venture capital fund investing in healthcare IT and medical device companies; deployed capital across portfolio companies and produced top quartile returns with multiple exits. For limited partner investors and healthcare startup founders.

2Mutual Capital Partners Fund IV (MCPF IV)
CategoryVenture Capital Fund
Description

MCP's current active venture capital fund investing in healthcare IT and medical device companies; first investment was the $20M Authenticx Series B in January 2023. For limited partner investors and healthcare startup founders.

3Healthcare IT and Medical Device Investment Capital
CategoryVenture Capital Investment
Description

Equity capital deployment across Series A through Series D rounds in healthcare IT and medical device companies, including recent investments in Authenticx, Cooler Heads, iotaMotion, Catalyst OrthoScience, SPR Therapeutics, Olio Health, Redi.Health, Checkpoint Surgical, and Elevation Spine. For early-to-growth-stage healthcare startups meeting MCP's investment criteria ($1M+ run-rate revenue, 50%+ gross margins, 5+ reference customers, strong management nucleus).

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Columbus, Ohio-based venture capital firm and startup accelerator operating in the same Ohio/Midwest regional ecosystem as MCP. While Rev1 invests across multiple sectors rather than exclusively healthcare, both firms are anchor regional VCs in Ohio with comparable check sizes.

TypeRegional player
Description

Cincinnati-based seed and early-stage venture capital firm investing across Ohio and the broader Midwest. Comparable to MCP's regional focus and stage, though CincyTech is sector-agnostic rather than healthcare-specialized.

TypeDirect peer
Description

Healthcare and technology growth equity firm that has co-invested with MCP on Catalyst OrthoScience ($12.3M Series D), Checkpoint Surgical ($16M), and SPR Therapeutics ($37M). Both firms operate in the healthcare growth equity space with similar investment stages.

TypeBroad incumbent
Description

Cleveland-based venture development organization with a broader Ohio and Northeast Ohio focus. Their JumpStart NEXT Fund participated in Checkpoint Surgical's $16M financing alongside MCP, though JumpStart operates across multiple sectors, not exclusively healthcare.

TypeDirect peer
Description

Chicago-based growth equity firm with a strong healthcare vertical. Participated in Checkpoint Surgical's $16M capital raise alongside MCP, and operates with similar stage and sector focus in the healthcare growth equity space.

TypeDirect peer
Description

Ann Arbor, Michigan-based healthcare venture capital firm investing in medical devices and healthcare IT. Shares MCP's healthcare-only thesis and Midwest geographic focus, with comparable check sizes and stage preferences.

TypeDirect peer
Description

Healthcare-focused growth equity firm that led SPR Therapeutics' $85M financing ($25M Series D-1 + $60M debt) with MCP as a participating incumbent investor. Operates in the same healthcare growth equity category as MCP.

TypeDirect peer
Description

Healthcare-focused growth equity firm that led Authenticx's $20M Series B and Redi Health's $14M Series B with MCP participation. Operates as a healthcare growth investor comparable to MCP's thesis and check sizes.

TypeDirect peer
Description

Healthcare-focused venture capital firm that has repeatedly co-invested with MCP, including on Catalyst OrthoScience ($15M/$12.3M rounds), SPR Therapeutics ($85M financing), and others. Both firms target healthcare IT and medical device companies with similar deal sizes and stages.

TypeDirect peer
Description

Atlanta-based growth equity firm that co-invested with MCP in Olio Health's $13M Series A. Targets healthcare and technology growth opportunities with comparable investment stages.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment43 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mutual Capital Partners

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm founded in 2004 that invests in healthcare IT and medical device companies across Ohio and the broader Midwest, managing four successive funds (MCPF I-IV) with a focus on early to growth-stage companies demonstrating strong unit economics.

What Mutual Capital Partners does

Mutual Capital Partners (MCP) is a Cleveland, Ohio-based venture capital firm founded in 2004 by Bill Trainor and Wayne Wallace, focused exclusively on healthcare IT and medical device companies. The firm manages four successive funds (MCPF I through MCPF IV), with Fund IV currently active and having made its first investment in early 2023. MCP invests in early to growth-stage companies located primarily in Ohio and the broader Midwest, deliberately avoiding major tech centers to source differentiated deal flow.

The firm's investment criteria target companies with at least $1 million in run-rate revenue, gross margins of 50% or higher, a strong management team, and at least five reference customers who are renewing or expanding. Typical check sizes range from approximately $11M to $15M, deployed across Series A through Series D rounds and select debt financings. Notable portfolio holdings span Cooler Heads (scalp cooling), iotaMotion (cochlear implant insertion systems), Authenticx (voice analytics), Catalyst OrthoScience (orthopedic implants), Checkpoint Surgical, Elevation Spine, Olio Health (post-acute workflow), Redi.Health, and SPR Therapeutics (pain management), with exits including Cardinal Commerce (Visa, 2016), Cleveland HeartLab (Quest Diagnostics, 2017), TGX Medical Systems (Integra LifeSciences, 2017), OrthoHelix Surgical Designs (Tornier, 2012), and RevLocal (Hibu, 2024). Fund I achieved top-quartile returns.

MCP operates as a limited partnership generating revenue through traditional venture capital fund management economics—management fees on committed and deployed capital plus carried interest on successful exits. The four-person team (two co-founder Managing Directors, one Principal, one Senior Associate) sources deals through direct outreach, network introductions, and partnerships with regional angel funds and economic development entities. The firm does not develop proprietary technology products; its competitive position rests on regional deal flow access, co-investment syndicates with RC Capital, River Cities Capital, Blue Heron Capital, Fulcrum Equity Partners, and Revelation Partners, and a strong historical exit track record within healthcare technology investing.

Mutual Capital Partners firmographics

Firmographics
Name
Mutual Capital Partners
Legal name
Mutual Capital Partners
Website
https://mutualcapitalpartners.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Short description
Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm founded in 2004 that invests in healthcare IT and medical device companies across Ohio and the broader Midwest, managing four successive funds (MCPF I-IV) with a focus on early to growth-stage companies demonstrating strong unit economics.
Ownership category
akta.pro rank

Mutual Capital Partners industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAJ
Venture Capital Fund-of-Funds / Multi-Manager Platforms

Keywords

  • Healthcare venture capital
  • Medical device investing
  • Healthcare IT funding
  • Early-stage growth capital
  • Midwest venture capital

Where Mutual Capital Partners is headquartered

Location

Headquarters

HQ city
Westlake
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mutual Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management: MCP generates revenue through traditional venture capital fund management, including management fees on deployed capital and carried interest (performance fees) on successful portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Mutual Capital Partners product offering

Product offering

Core offering

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that manages multiple funds (MCPF I through MCPF IV) investing equity capital into early- and growth-stage healthcare IT and medical device companies, primarily in Ohio and the broader Midwest. The firm provides portfolio companies with capital, fundraising guidance, networking support, and hands-on operational partnership in addition to financial investment. Investment criteria require companies to have $1M+ in run-rate revenue, 50%+ gross margins, a strong management nucleus, at least five reference customers, and a location outside of major tech centers.

Product overview

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that invests in healthcare IT and medical device companies. The firm operates multiple investment funds (MCPF I through MCPF IV) and provides capital, networking, and advisory support to portfolio companies. The firm's investment focus is on healthcare technology companies with strong management teams, at least $1 million in run-rate revenue, and 50%+ gross margins, located primarily in Ohio and the Midwest. As a VC firm, MCP does not offer a technology product; its services are investment capital deployment and portfolio company support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mutual Capital Partners Fund I (MCPF I) MCP's inaugural venture capital fund investing in healthcare IT and medical device companies; deployed capital across portfolio companies and produced top quartile returns with multiple exits. For limited partner investors and healthcare startup founders.
  • Mutual Capital Partners Fund IV (MCPF IV) MCP's current active venture capital fund investing in healthcare IT and medical device companies; first investment was the $20M Authenticx Series B in January 2023. For limited partner investors and healthcare startup founders.
  • Healthcare IT and Medical Device Investment Capital Equity capital deployment across Series A through Series D rounds in healthcare IT and medical device companies, including recent investments in Authenticx, Cooler Heads, iotaMotion, Catalyst OrthoScience, SPR Therapeutics, Olio Health, Redi.Health, Checkpoint Surgical, and Elevation Spine. For early-to-growth-stage healthcare startups meeting MCP's investment criteria ($1M+ run-rate revenue, 50%+ gross margins, 5+ reference customers, strong management nucleus).

Quantifiable outcome

  • Top quartile returns on Fund I

Companies that use Mutual Capital Partners

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Mutual Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mutual Capital Partners partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Mutual Capital Partners competitors and assessment

Company assessment

Regional players

  • Rev1 Ventures: Columbus, Ohio-based venture capital firm and startup accelerator operating in the same Ohio/Midwest regional ecosystem as MCP. While Rev1 invests across multiple sectors rather than exclusively healthcare, both firms are anchor regional VCs in Ohio with comparable check sizes.
  • CincyTech: Cincinnati-based seed and early-stage venture capital firm investing across Ohio and the broader Midwest. Comparable to MCP's regional focus and stage, though CincyTech is sector-agnostic rather than healthcare-specialized.

Direct peers

  • River Cities Capital Funds: Healthcare and technology growth equity firm that has co-invested with MCP on Catalyst OrthoScience ($12.3M Series D), Checkpoint Surgical ($16M), and SPR Therapeutics ($37M). Both firms operate in the healthcare growth equity space with similar investment stages.
  • First Analysis: Chicago-based growth equity firm with a strong healthcare vertical. Participated in Checkpoint Surgical's $16M capital raise alongside MCP, and operates with similar stage and sector focus in the healthcare growth equity space.
  • Arboretum Ventures: Ann Arbor, Michigan-based healthcare venture capital firm investing in medical devices and healthcare IT. Shares MCP's healthcare-only thesis and Midwest geographic focus, with comparable check sizes and stage preferences.
  • Revelation Partners: Healthcare-focused growth equity firm that led SPR Therapeutics' $85M financing ($25M Series D-1 + $60M debt) with MCP as a participating incumbent investor. Operates in the same healthcare growth equity category as MCP.
  • Blue Heron Capital: Healthcare-focused growth equity firm that led Authenticx's $20M Series B and Redi Health's $14M Series B with MCP participation. Operates as a healthcare growth investor comparable to MCP's thesis and check sizes.
  • RC Capital: Healthcare-focused venture capital firm that has repeatedly co-invested with MCP, including on Catalyst OrthoScience ($15M/$12.3M rounds), SPR Therapeutics ($85M financing), and others. Both firms target healthcare IT and medical device companies with similar deal sizes and stages.
  • Fulcrum Equity Partners: Atlanta-based growth equity firm that co-invested with MCP in Olio Health's $13M Series A. Targets healthcare and technology growth opportunities with comparable investment stages.

Broad incumbents

  • JumpStart Inc. Cleveland-based venture development organization with a broader Ohio and Northeast Ohio focus. Their JumpStart NEXT Fund participated in Checkpoint Surgical's $16M financing alongside MCP, though JumpStart operates across multiple sectors, not exclusively healthcare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Mutual Capital Partners social profiles

Digital presence

Mutual Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mutual Capital Partners leadership team

Management profile

Number of profiles

Profiles4 records

Mutual Capital Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mutual Capital Partners M&A and investment

M&A and investment

M&A

Investments43 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mutual Capital Partners

What does Mutual Capital Partners do?

Mutual Capital Partners is a Cleveland, Ohio-based venture capital firm that manages multiple funds (MCPF I through MCPF IV) investing equity capital into early- and growth-stage healthcare IT and medical device companies, primarily in Ohio and the broader Midwest. The firm provides portfolio companies with capital, fundraising guidance, networking support, and hands-on operational partnership in addition to financial investment. Investment criteria require companies to have $1M+ in run-rate revenue, 50%+ gross margins, a strong management nucleus, at least five reference customers, and a location outside of major tech centers.

Is Mutual Capital Partners a public or private company?

Mutual Capital Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Mutual Capital Partners founded?

Mutual Capital Partners was founded in 2004. It employs 1 to 10 people.

Where is Mutual Capital Partners based?

Mutual Capital Partners is headquartered in Westlake, United States, in the North America region.

How does Mutual Capital Partners make money?

One revenue line is on record: fund Management.

Who are Mutual Capital Partners's main competitors?

Regional players on record are Rev1 Ventures and CincyTech. Direct peers are River Cities Capital Funds, First Analysis, Arboretum Ventures, Revelation Partners, Blue Heron Capital, RC Capital and Fulcrum Equity Partners. JumpStart Inc. is listed as a broad incumbent.

Does Mutual Capital Partners have an API?

No public API is recorded for Mutual Capital Partners.

What industry is Mutual Capital Partners in?

Mutual Capital Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsTYBR Health Raises $30M in Series A FundingTYBR Health, a Houston-based medical technology company, raised $30M in Series A funding led by Vensana Capital and Mutual Capital Partners. The company will use the funds to expand operations and development efforts. It develops the B3 GEL System, an FDA-cleared hydrogel for post-operative tendon mobility.Venture Capital Access OnlineTYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® SystemTYBR Health announced a $30 million Series A financing led by Vensana Capital and Mutual Capital Partners, with participation from Neovate Capital Partners and existing investors. The company will use the funds to expand commercial access to its FDA-cleared B3 GEL System, broaden indications, and run clinical studies on tissue protection during orthopedic surgery.HIT ConsultantOlio Secures $11M to Scale Care Coordination PlatformOlio, a care coordination platform, raised $11M in Series B funding led by Fulcrum Equity Partners with participation from Mutual Capital Partners. The capital will expand product offerings and accelerate go-to-market efforts to deepen impact on healthcare organizations nationwide.PR NewswireOlio Raises $11M Series B Funding to Expand Product Innovation and Market ReachOlio closed an $11 million Series B funding round led by Fulcrum Equity Partners with participation from Mutual Capital Partners. The healthcare care coordination platform will use the capital to expand product offerings and accelerate go-to-market initiatives. The company aims to deepen its impact on healthcare organizations nationwide.American City Business JournalsMutual Capital Partners closes fund with $32 millionMutual Capital Partners, a Westlake, Ohio firm, closed a fund of $32 million. The firm plans to back up to 10 early-stage health care companies across the Midwest and other markets.PYMNTS.comOlio Raises $13M to Grow Healthcare EcosystemOlio Health has secured $13 million in Series A funding to expand its workflow and collaboration platform designed for the post-acute care ecosystem. The investment, which includes participation from Fulcrum Equity Partners and Mutual Capital Partners, will be used to accelerate product development and hire key talent. This capital infusion aims to improve communication between health systems, payers, and providers to enhance value-based care outcomes.Ortho Spine NewsMedical device firm reels in $12M investment – Ortho Spine NewsCatalyst OrthoScience, a Naples-based medical device company focused on upper extremity orthopedics, raised $12.3 million in a Series D round led by Cincinnati-based River Cities Capital and Mutual Capital Partners. Tamiami Angel Fund IV invested $669,791, bringing its total stake to $2.38 million, the largest from any Tamiami portfolio company. CEO Brian Hutchison said the funding will expand the shoulder arthroplasty product portfolio and team.The Columbus DispatchColumbus startup looks to improve the health of those with multiple chronic conditionsRedi.Health, a Columbus startup, announced funding led by Mutual Capital Partners to expand its platform for patients with multiple chronic conditions. The company, with seven employees, expects to grow through the year. It aims to help patients manage medications and access services like financial aid and transportation.VC News DailyRedi.Health Secures FinancingRedi.Health, a Columbus, Ohio-based health management technology provider, has secured seed funding led by Mutual Capital Partners with additional participation from M25, Rev1 Ventures, and Plug and Play. The company offers a patient-centric platform that combines health management with partnered pharmaceutical manufacturer support to improve medication adherence and quality of life. The specific amount of the seed funding was not disclosed.FinSMEsCheckpoint Surgical Closes $8.8M Equity FinancingCheckpoint Surgical, a Cleveland-based medical device company, completed an $8.8M preferred equity round led by Mutual Capital Partners. The funds will expand sales and marketing, advance new product opportunities in nerve regeneration and neuroma pain, and bolster its executive team.